Endoglin, a coreceptor of the TGFβ1 and BMP receptor, has been suggested as a novel target to induce the BMP anti-fibrotic effect, as endoglin neutralization limits cardiac fibrosis in the TAC model by increasing BMP9 cardiac levels and reducing smad3 activation [42,43]. Here, ENG is linked to persistent truncus arteriosus.